Analyst Chris Shibutani initiated the stock with a buy rating, saying the company has a promising new oral treatment in development for plaque psoriasis.
Author: admin
Beware these stocks: Analysts see a rough year ahead for these companies
CNBC Pro looked at stocks that are poised to lose the most in 2023 based on the average analyst price target, according to FactSet.
Southeast Asian venture capital firms expect to be pickier in 2023 than in 2022
Venture capital firms in Southeast Asia will probably be pickier next year, with valuations plunging and macro headwinds slowing down growth in 2022.
Bill Gates: ‘Our grandchildren will grow up in a world that is dramatically worse off’ if we don’t fix climate change
In a letter published on his personal blog on Tuesday, Bill Gates addresses areas he has been focusing on in the past year and what lies ahead.
FTX founder Bankman-Fried sent back to Bahamas jail in day of courtroom chaos
Sam Bankman-Fried is returning to a Bahamian prison after demanding to see a copy of his federal indictment.
Amazon stock gives up last of its pandemic gains after almost 50% slump in 2022
Amazon shares have been battered this year by a broader market sell-off tied to soaring inflation, a worsening economy, and rising interest rates.
From recovery to regulation: How China’s tech giants could fare in 2023 after a bruising year
Investors cautious heading into next year in regards to Chinese tech stocks with analysts expecting regulation to be more predictable and growth to accelerate.
Stocks making the biggest moves midday: Disney, Tesla, Mesa Air and more
These are the stocks posting the largest moves midday.
21% of investors don’t think they pay investing-related fees. Here’s why they’re wrong — and how it costs them
Twenty-one percent of people incorrectly believe they don’t pay fees to invest in non-retirement accounts, the FINRA Investor Education Foundation has found.
Binance’s native BNB token plunges to lowest since July as concerns mount about withdrawals, FTX ties
Crypto exchange giant Binance, the firm that would potentially bail out FTX, is facing its own questions now, and investors are selling out of its native coin.